Get the Stockscreener App
0.5365
7.54%
0.0376
Bioatla Inc stock is traded at $0.5365, with a volume of 987.15K.
It is up +7.54% in the last 24 hours and up +53.29% over the past month.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
See More
Previous Close:
$0.4989
Open:
$0.5
24h Volume:
987.15K
Relative Volume:
1.54
Market Cap:
$31.50M
Revenue:
-
Net Income/Loss:
$-123.46M
P/E Ratio:
-0.2071
EPS:
-2.59
Net Cash Flow:
$-104.11M
1W Performance:
+17.78%
1M Performance:
+53.29%
6M Performance:
+53.29%
1Y Performance:
-71.00%
1-Day Range:
$0.4797
$0.5426
1-Week Range:
$0.4382
$0.5426
52-Week Range:
$0.2601
$2.525
Bioatla Inc Stock (BCAB) Company Profile
Name
Bioatla Inc
Sector
Industry
Phone
858-558-0708
Address
11085 TORREYANA ROAD, SAN DIEGO
Compare BCAB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BCAB
Bioatla Inc
|
0.5365 | 29.30M | 0 | -123.46M | -104.11M | -2.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Bioatla Inc Stock (BCAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Nov-13-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Sep-15-22 | Initiated | JMP Securities | Mkt Outperform |
| May-05-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-21-22 | Initiated | H.C. Wainwright | Buy |
| Oct-15-21 | Resumed | BTIG Research | Buy |
| Jun-28-21 | Initiated | ROTH Capital | Buy |
| May-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Jan-11-21 | Initiated | BTIG Research | Buy |
| Jan-11-21 | Initiated | Credit Suisse | Outperform |
| Jan-11-21 | Initiated | JP Morgan | Overweight |
| Jan-11-21 | Initiated | Jefferies | Buy |
View All
Bioatla Inc Stock (BCAB) Latest News
Will BioAtla Inc. benefit from macro trendsMarket Performance Summary & Fast Entry High Yield Stock Tips - Newser
How to monitor BioAtla Inc. with trend dashboardsQuarterly Earnings Report & Reliable Volume Spike Trade Alerts - Newser
Will BioAtla Inc. stock recover after earnings2025 Fundamental Recap & Safe Entry Zone Tips - خودرو بانک
Is BioAtla Inc. affected by consumer sentimentRecession Risk & Real-Time Chart Pattern Alerts - خودرو بانک
What is the next catalyst for BioAtla Inc.2025 AllTime Highs & Verified High Yield Trade Plans - خودرو بانک
Can BioAtla Inc. navigate macro headwinds2025 AllTime Highs & Daily Stock Trend Reports - خودرو بانک
What analysts say about BioAtla Inc. stockJuly 2025 WrapUp & Community Trade Idea Sharing - خودرو بانک
Will BioAtla Inc. benefit from AI trends2025 Technical Patterns & Technical Entry and Exit Tips - خودرو بانک
Does BioAtla Inc. stock benefit from AI growthEntry Point & Expert Curated Trade Ideas - خودرو بانک
When is the best time to exit BioAtla Inc.July 2025 Patterns & Free Community Consensus Stock Picks - Newser
Will BioAtla Inc. rebound enough to break even2025 Top Decliners & Step-by-Step Swing Trade Plans - Newser
Does BioAtla Inc. stock have upside surprise potential2025 Market WrapUp & Weekly Breakout Opportunity Watchlist - 강소기업뉴스
Earnings visualization tools for BioAtla Inc.Earnings Summary Report & Safe Capital Growth Trade Ideas - Newser
Risk Check: Is BioAtla Inc. affected by consumer sentimentWeekly Trend Summary & Long-Term Growth Plans - خودرو بانک
Combining price and volume data for BioAtla Inc.Quarterly Market Review & Community Consensus Trade Signals - Newser
Is BioAtla Inc. exposed to political riskMarket Growth Review & Real-Time Buy Signal Notifications - خودرو بانک
What BioAtla Inc (NASDAQ: BCAB) Stock Didn’t Tell You This Week - stocksregister.com
Combining machine learning predictions for BioAtla Inc.2025 Performance Recap & Reliable Volume Spike Trade Alerts - Newser
Will BioAtla Inc. stock go up in YEAR2025 Breakouts & Breakdowns & Risk Adjusted Buy/Sell Alerts - خودرو بانک
BioAtla Inc. stock momentum explained2025 Top Decliners & Daily Risk Controlled Trade Plans - Newser
Is it time to cut losses on BioAtla Inc.Trend Reversal & Safe Capital Allocation Plans - Newser
Tools to monitor BioAtla Inc. recovery probability2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - Newser
Using economic indicators to assess BioAtla Inc. potential2025 Investor Takeaways & AI Driven Price Forecasts - Newser
Building trade automation scripts for BioAtla Inc.July 2025 Sentiment & Safe Entry Point Alerts - Newser
Short interest data insights for BioAtla Inc.July 2025 EndofMonth & Real-Time Stock Movement Alerts - Newser
Multi factor analysis applied to BioAtla Inc.July 2025 Review & Free Safe Capital Growth Stock Tips - Newser
Using Bollinger Bands to evaluate BioAtla Inc.July 2025 Update & Safe Capital Allocation Plans - Newser
Applying chart zones and confluence areas to BioAtla Inc.Swing Trade & Smart Investment Allocation Tips - Newser
Visualizing BioAtla Inc. stock with heatmaps2025 Volume Leaders & Daily Price Action Insights - Newser
Volume Profile Shows Strong Base for BioAtla Inc. getLinesFromResByArray error: size == 0 - 강소기업뉴스
Is It Too Early to Call Recovery in BioAtla Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
What institutional flow reveals about BioAtla Inc.July 2025 Recap & Verified Swing Trading Watchlist - Newser
Analyzing net buyer seller activity in BioAtla Inc.2025 Year in Review & Expert-Curated Trade Recommendations - Newser
BioAtla Inc. stock trend outlook and recovery path2025 Buyback Activity & Daily Profit Maximizing Trade Tips - Newser
Published on: 2025-08-30 23:36:56 - Newser
Using data filters to optimize entry into BioAtla Inc.July 2025 Chart Watch & Community Trade Idea Sharing Platform - Newser
Bioatla Inc Stock (BCAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):